/

Empresas

HA

No verificado

HAYA Therapeutics

Sobre qué escribimos

BiotecnologíaCardiologíaFarmacéuticaMultimediaOncología

4 Comunicados de prensa

Ver todos los comunicados de prensa

03/06/2025

HAYA Therapeutics Moves San Diego Operations to Lilly Gateway Labs® to Accelerate Development of RNA-Guided Therapeutics Platform

Fuente

HAYA Therapeutics

Editor

1.00

0

13/03/2025

HAYA Therapeutics Appoints Former Exscientia Executive Dr. Richard Law as Chief Business Officer

Fuente

HAYA Therapeutics

Editor

1.00

0

11/09/2024

Multimedia

Mercado laboral

Cardiología

Biotecnología

Sanidad

Salud

Farmacéutica

Oncología

Ciencia

Medicina - Varios

HAYA Therapeutics Appoints Cardiology and Genetics Medicines Expert Jordan Shin, M.D., Ph.D. as Chief Medical Officer

Fuente

HAYA Therapeutics

Editor

1.00

0

01/07/2024

HAYA Therapeutics Co-Founders Win Inaugural Andreas & Thomas Struengmann Award

Fuente

HAYA Therapeutics

Editor

1.00

0

Seguidores

0

Compatibilidad

0